Rivaroxaban
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9834 publications
Efficacy and safety of direct oral anticoagulants for intermediate stroke risk in patients with atrial fibrillation (SINGLE-AF): Study design and protocol.
Journal: Heart rhythm O2
Published: March 30, 2026
Inflation Reduction Act impact on the hematology/oncology treatment landscape.
Journal: The American journal of managed care
Published: March 26, 2026
Characteristics and outcomes of patients with diabetes mellitus selected for dual pathway inhibition in clinical practice: The XATOA registry.
Journal: Vascular medicine (London, England)
Published: March 24, 2026
Advancing Point-of-Care Analysis: The Future of Thromboelastographic DOAC-Detection: A Systematic Review.
Journal: Seminars in thrombosis and hemostasis
Published: March 18, 2026
Evaluating the incidence of thrombosis in patients with concurrent second-generation androgen receptor inhibitor therapy and direct oral anticoagulants: A retrospective chart review.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 18, 2026
Safety of Prothrombin Complex Concentrate for Emergency Surgery According to the Oral Factor Xa Inhibitor Level.
Journal: Thrombosis and haemostasis
Published: March 17, 2026
Effectiveness and safety of rivaroxaban in pediatric patients with coronary artery diseases: a case series study
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: March 16, 2026
Acute unintentional single-substance pediatric exposures to direct factor Xa inhibitors reported to US Poison Centers, 2011-2019.
Journal: Clinical toxicology (Philadelphia, Pa.)
Published: March 16, 2026
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.
Journal: The New England journal of medicine
Published: March 11, 2026
Last Updated: 04/28/2026